OBIO and MDT Related Headlines

Go Back

Aug 10, 2026 04:12PM Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates
May 12, 2026 04:18PM Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
May 12, 2026 08:30AM Orchestra BioMed targets BACKBEAT trial completion by Q3 2026
May 12, 2026 08:30AM Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027
May 6, 2026 08:03AM Orchestra BioMed receives $20 million from Medtronic under financing pact
May 6, 2026 08:01AM Orchestra BioMed receives $15 million from Ligand under financing agreement
May 6, 2026 08:01AM Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
May 6, 2026 08:00AM Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement
Apr 30, 2026 09:00AM FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy
Apr 23, 2026 12:00PM Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026
Mar 12, 2026 08:17AM Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
Nov 11, 2025 09:00AM Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
Nov 10, 2025 04:10PM Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
Oct 9, 2025 08:00AM Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit

OBIO and MDT Related Press Releases

Go Back

Aug 10, 2026 04:12PM Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates
May 12, 2026 04:18PM Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
May 12, 2026 08:30AM Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027
May 6, 2026 08:01AM Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
May 6, 2026 08:00AM Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement
Apr 30, 2026 09:00AM FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy
Apr 23, 2026 12:00PM Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026
Mar 12, 2026 08:17AM Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
Nov 11, 2025 09:00AM Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
Nov 10, 2025 04:10PM Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
Oct 9, 2025 08:00AM Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit

OBIO and MDT Related SEC Filings

Go Back